Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Nanoscope Therapeutics is a biotechnology company developing a new generation of optogenetic therapy designed to restore vision lost to retinal degeneration. Its MCO 010 platform is the first broad-spectrum, fast-response optogenetic technology that has demonstrated vision restoration in clinical trials for patients with severe vision loss.
Parse Score